Higher levels of the soluble receptor for advanced glycation end products and lower levels of the extracellular newly identified receptor for advanced glycation end products were associated with lipid-lowering drugs in patients with type 1 diabetes: a comparative cross-sectional study

BACKGROUND: The receptors for advanced glycation end products (RAGE) are increased in atherosclerotic plaques. Soluble (s)RAGE decreases, whereas the extracellular newly identified receptor for advanced glycation end products (EN-RAGE) increases inflammatory responses mediated by RAGE. The aims were...

Descripción completa

Detalles Bibliográficos
Autores principales: Melin, Eva O., Dereke, Jonatan, Hillman, Magnus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557054/
https://www.ncbi.nlm.nih.gov/pubmed/33054750
http://dx.doi.org/10.1186/s12944-020-01397-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7557054/
https://www.ncbi.nlm.nih.gov/pubmed/33054750
http://dx.doi.org/10.1186/s12944-020-01397-2

Ejemplares similares